Sehn, Laurie H <br/><br/>
Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma.  [electronic resource] 

 -  Hematology. American Society of Hematology. Education Program  2012 
 - 402-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1520-4383 
<br/><br/><label>Standard No.: </label>10.1182/asheducation-2012.1.402  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor<br/>Clinical Trials as Topic<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Female<br/>Gene Expression Profiling<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--blood<br/>Male<br/>Medical Oncology--methods<br/>Middle Aged<br/>Prednisone--therapeutic use<br/>Prognosis<br/>Rituximab<br/>Time Factors<br/>Treatment Outcome<br/>Vincristine--therapeutic use